Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Allan currently holds 20,598 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Allan has been a net seller of STOK stock. They have purchased $0 and sold $1.8M worth of shares.
Jonathan Allan's most recent insider trade was on Oct 2, 2026, when they sold 627 shares at $26.33 per share.
Jonathan Allan serves as Executive at Stoke Therapeutics, Inc. (STOK). They have executed 38 insider transactions totaling $1.8M over their tenure at the company.
Jonathan Allan holds the position of Executive at Stoke Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Jonathan Allan has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan Allan was on Sep 2, 2025, when they sold $300.5K worth of STOK shares. This transaction involved 14,922 shares at $20.14 per share.
Jonathan Allan currently owns 20,598 shares of Stoke Therapeutics, Inc. (STOK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Allan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Allan has 38 Form 4 filings on record as an insider at Stoke Therapeutics, Inc..
Set alerts for Jonathan Allan and 40,000+ other insiders.